US 12194090
Tetanus vaccine platform for embedding COVID-19 vaccine
granted A61KA61K2039/542A61K2039/543
Quick answer
US patent 12194090 (Tetanus vaccine platform for embedding COVID-19 vaccine) held by Prime Bio, Inc. expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Prime Bio, Inc.
- Grant date
- Tue Jan 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/542, A61K2039/543, A61K2039/55505, A61K2039/55544